Academic Journal
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
| العنوان: | BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance |
|---|---|
| المؤلفون: | Ksenija Nesic, John J. Krais, Yifan Wang, Cassandra J. Vandenberg, Pooja Patel, Kathy Q. Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E. Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S. Penington, Franziska Geissler, Elizabeth Kyran, Robert Betsch, Lijun Xu, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Iain McNeish, Gayanie Ratnayake, Nadia Traficante, Australian Ovarian Cancer Study, Anna DeFazio, David D. L. Bowtell, Thomas C. Harding, Kevin Lin, Elizabeth M. Swisher, Olga Kondrashova, Clare L. Scott, Neil Johnson, Matthew J. Wakefield |
| المصدر: | Molecular Cancer, Vol 23, Iss 1, Pp 1-10 (2024) |
| بيانات النشر: | BMC |
| سنة النشر: | 2024 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| الوصف: | PARP inhibitor (PARPi) therapy has transformed outcomes for patients with homologous recombination DNA repair (HRR) deficient ovarian cancers, for example those with BRCA1 or BRCA2 gene defects. Unfortunately, PARPi resistance is common. Multiple resistance mechanisms have been described, including secondary mutations that restore the HR gene reading frame. BRCA1 splice isoforms △11 and △11q can contribute to PARPi resistance by splicing out the mutation-containing exon, producing truncated, partially functional proteins. However, the clinical impacts and underlying drivers of BRCA1 exon skipping are not fully understood. We analyzed nine ovarian and breast cancer patient derived xenografts (PDX) with BRCA1 exon 11 frameshift mutations for exon skipping and therapy response, including a matched PDX pair derived from a patient pre- and post-chemotherapy/PARPi. BRCA1 exon 11 skipping was elevated in PARPi resistant PDX tumors. Two independent PDX models acquired secondary BRCA1 splice site mutations (SSMs) that drive exon skipping, confirmed using qRT-PCR, RNA sequencing, immunoblotting and minigene modelling. CRISPR/Cas9-mediated disruption of splicing functionally validated exon skipping as a mechanism of PARPi resistance. SSMs were also enriched in post-PARPi ovarian cancer patient cohorts from the ARIEL2 and ARIEL4 clinical trials. Few PARPi resistance mechanisms have been confirmed in the clinical setting. While secondary/reversion mutations typically restore a gene’s reading frame, we have identified secondary mutations in patient cohorts that hijack splice sites to enhance mutation-containing exon skipping, resulting in the overexpression of BRCA1 hypomorphs, which in turn promote PARPi resistance. Thus, BRCA1 SSMs can and should be clinically monitored, along with frame-restoring secondary mutations. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1476-4598 |
| Relation: | https://doi.org/10.1186/s12943-024-02048-1; https://doaj.org/toc/1476-4598; https://doaj.org/article/8f0a9b712db94dd79db01d43d570add9 |
| DOI: | 10.1186/s12943-024-02048-1 |
| الاتاحة: | https://doi.org/10.1186/s12943-024-02048-1 https://doaj.org/article/8f0a9b712db94dd79db01d43d570add9 |
| رقم الانضمام: | edsbas.F0345FE0 |
| قاعدة البيانات: | BASE |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.F0345FE0 995 3 Academic Journal academicJournal 995.377258300781 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.F0345FE0&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1186/s12943-024-02048-1# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsbas&genre=article&issn=14764598&ISBN=&volume=&issue=&date=20240101&spage=&pages=&title=Molecular Cancer&atitle=BRCA1%20secondary%20splice-site%20mutations%20drive%20exon-skipping%20and%20PARP%20inhibitor%20resistance&id=DOI:10.1186/s12943-024-02048-1 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Ksenija+Nesic%22">Ksenija Nesic</searchLink><br /><searchLink fieldCode="AR" term="%22John+J%2E+Krais%22">John J. Krais</searchLink><br /><searchLink fieldCode="AR" term="%22Yifan+Wang%22">Yifan Wang</searchLink><br /><searchLink fieldCode="AR" term="%22Cassandra+J%2E+Vandenberg%22">Cassandra J. Vandenberg</searchLink><br /><searchLink fieldCode="AR" term="%22Pooja+Patel%22">Pooja Patel</searchLink><br /><searchLink fieldCode="AR" term="%22Kathy+Q%2E+Cai%22">Kathy Q. Cai</searchLink><br /><searchLink fieldCode="AR" term="%22Tanya+Kwan%22">Tanya Kwan</searchLink><br /><searchLink fieldCode="AR" term="%22Elizabeth+Lieschke%22">Elizabeth Lieschke</searchLink><br /><searchLink fieldCode="AR" term="%22Gwo-Yaw+Ho%22">Gwo-Yaw Ho</searchLink><br /><searchLink fieldCode="AR" term="%22Holly+E%2E+Barker%22">Holly E. Barker</searchLink><br /><searchLink fieldCode="AR" term="%22Justin+Bedo%22">Justin Bedo</searchLink><br /><searchLink fieldCode="AR" term="%22Silvia+Casadei%22">Silvia Casadei</searchLink><br /><searchLink fieldCode="AR" term="%22Andrew+Farrell%22">Andrew Farrell</searchLink><br /><searchLink fieldCode="AR" term="%22Marc+Radke%22">Marc Radke</searchLink><br /><searchLink fieldCode="AR" term="%22Kristy+Shield-Artin%22">Kristy Shield-Artin</searchLink><br /><searchLink fieldCode="AR" term="%22Jocelyn+S%2E+Penington%22">Jocelyn S. Penington</searchLink><br /><searchLink fieldCode="AR" term="%22Franziska+Geissler%22">Franziska Geissler</searchLink><br /><searchLink fieldCode="AR" term="%22Elizabeth+Kyran%22">Elizabeth Kyran</searchLink><br /><searchLink fieldCode="AR" term="%22Robert+Betsch%22">Robert Betsch</searchLink><br /><searchLink fieldCode="AR" term="%22Lijun+Xu%22">Lijun Xu</searchLink><br /><searchLink fieldCode="AR" term="%22Fan+Zhang%22">Fan Zhang</searchLink><br /><searchLink fieldCode="AR" term="%22Alexander+Dobrovic%22">Alexander Dobrovic</searchLink><br /><searchLink fieldCode="AR" term="%22Inger+Olesen%22">Inger Olesen</searchLink><br /><searchLink fieldCode="AR" term="%22Rebecca+Kristeleit%22">Rebecca Kristeleit</searchLink><br /><searchLink fieldCode="AR" term="%22Amit+Oza%22">Amit Oza</searchLink><br /><searchLink fieldCode="AR" term="%22Iain+McNeish%22">Iain McNeish</searchLink><br /><searchLink fieldCode="AR" term="%22Gayanie+Ratnayake%22">Gayanie Ratnayake</searchLink><br /><searchLink fieldCode="AR" term="%22Nadia+Traficante%22">Nadia Traficante</searchLink><br /><searchLink fieldCode="AR" term="%22Australian+Ovarian+Cancer+Study%22">Australian Ovarian Cancer Study</searchLink><br /><searchLink fieldCode="AR" term="%22Anna+DeFazio%22">Anna DeFazio</searchLink><br /><searchLink fieldCode="AR" term="%22David+D%2E+L%2E+Bowtell%22">David D. L. Bowtell</searchLink><br /><searchLink fieldCode="AR" term="%22Thomas+C%2E+Harding%22">Thomas C. Harding</searchLink><br /><searchLink fieldCode="AR" term="%22Kevin+Lin%22">Kevin Lin</searchLink><br /><searchLink fieldCode="AR" term="%22Elizabeth+M%2E+Swisher%22">Elizabeth M. Swisher</searchLink><br /><searchLink fieldCode="AR" term="%22Olga+Kondrashova%22">Olga Kondrashova</searchLink><br /><searchLink fieldCode="AR" term="%22Clare+L%2E+Scott%22">Clare L. Scott</searchLink><br /><searchLink fieldCode="AR" term="%22Neil+Johnson%22">Neil Johnson</searchLink><br /><searchLink fieldCode="AR" term="%22Matthew+J%2E+Wakefield%22">Matthew J. Wakefield</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Molecular Cancer, Vol 23, Iss 1, Pp 1-10 (2024) ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => BMC ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2024 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Directory of Open Access Journals: DOAJ Articles ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => PARP inhibitor (PARPi) therapy has transformed outcomes for patients with homologous recombination DNA repair (HRR) deficient ovarian cancers, for example those with BRCA1 or BRCA2 gene defects. Unfortunately, PARPi resistance is common. Multiple resistance mechanisms have been described, including secondary mutations that restore the HR gene reading frame. BRCA1 splice isoforms △11 and △11q can contribute to PARPi resistance by splicing out the mutation-containing exon, producing truncated, partially functional proteins. However, the clinical impacts and underlying drivers of BRCA1 exon skipping are not fully understood. We analyzed nine ovarian and breast cancer patient derived xenografts (PDX) with BRCA1 exon 11 frameshift mutations for exon skipping and therapy response, including a matched PDX pair derived from a patient pre- and post-chemotherapy/PARPi. BRCA1 exon 11 skipping was elevated in PARPi resistant PDX tumors. Two independent PDX models acquired secondary BRCA1 splice site mutations (SSMs) that drive exon skipping, confirmed using qRT-PCR, RNA sequencing, immunoblotting and minigene modelling. CRISPR/Cas9-mediated disruption of splicing functionally validated exon skipping as a mechanism of PARPi resistance. SSMs were also enriched in post-PARPi ovarian cancer patient cohorts from the ARIEL2 and ARIEL4 clinical trials. Few PARPi resistance mechanisms have been confirmed in the clinical setting. While secondary/reversion mutations typically restore a gene’s reading frame, we have identified secondary mutations in patient cohorts that hijack splice sites to enhance mutation-containing exon skipping, resulting in the overexpression of BRCA1 hypomorphs, which in turn promote PARPi resistance. Thus, BRCA1 SSMs can and should be clinically monitored, along with frame-restoring secondary mutations. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1476-4598 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://doi.org/10.1186/s12943-024-02048-1; https://doaj.org/toc/1476-4598; https://doaj.org/article/8f0a9b712db94dd79db01d43d570add9 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1186/s12943-024-02048-1 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1186/s12943-024-02048-1<br />https://doaj.org/article/8f0a9b712db94dd79db01d43d570add9 ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.F0345FE0 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1186/s12943-024-02048-1
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Neoplasms. Tumors. Oncology. Including cancer and carcinogens
[Type] => general
)
[1] => Array
(
[SubjectFull] => RC254-282
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ksenija Nesic
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => John J. Krais
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yifan Wang
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Cassandra J. Vandenberg
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pooja Patel
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kathy Q. Cai
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tanya Kwan
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Elizabeth Lieschke
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Gwo-Yaw Ho
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Holly E. Barker
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Justin Bedo
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Silvia Casadei
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Andrew Farrell
)
)
)
[13] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Marc Radke
)
)
)
[14] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kristy Shield-Artin
)
)
)
[15] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jocelyn S. Penington
)
)
)
[16] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Franziska Geissler
)
)
)
[17] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Elizabeth Kyran
)
)
)
[18] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Robert Betsch
)
)
)
[19] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lijun Xu
)
)
)
[20] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Fan Zhang
)
)
)
[21] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Alexander Dobrovic
)
)
)
[22] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Inger Olesen
)
)
)
[23] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Rebecca Kristeleit
)
)
)
[24] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Amit Oza
)
)
)
[25] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Iain McNeish
)
)
)
[26] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Gayanie Ratnayake
)
)
)
[27] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nadia Traficante
)
)
)
[28] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Australian Ovarian Cancer Study
)
)
)
[29] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Anna DeFazio
)
)
)
[30] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => David D. L. Bowtell
)
)
)
[31] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Thomas C. Harding
)
)
)
[32] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kevin Lin
)
)
)
[33] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Elizabeth M. Swisher
)
)
)
[34] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Olga Kondrashova
)
)
)
[35] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Clare L. Scott
)
)
)
[36] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Neil Johnson
)
)
)
[37] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Matthew J. Wakefield
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2024
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 14764598
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Molecular Cancer
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |